Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Continuous Glucose Monitoring with Multiple Daily Insulin Treatment: Outcome Studies.

McGill JB, Ahmann A.

Diabetes Technol Ther. 2017 Jun;19(S3):S3-S12. doi: 10.1089/dia.2017.0090.

2.

An Audit of Clinical Practice in a Single Centre in Kuwait: Management of Children on Continuous Subcutaneous Insulin Infusion and Cardiovascular Risk Factors Screening.

Omar D, Alsanae H, Al Khawari M, Abdulrasoul M, Rahme Z, Al Refaei F, Behbehani K, Shaltout A.

Open Cardiovasc Med J. 2017 Feb 28;11:19-27. doi: 10.2174/1874192401711010019. eCollection 2017.

3.

Allergy to soft cannula of insulin pump in diabetic patient.

Chen YM, Huang H.

Pak J Med Sci. 2017 Jan-Feb;33(1):245-247. doi: 10.12669/pjms.331.11554.

4.

Who Should Be Considered for Islet Transplantation Alone?

Othonos N, Choudhary P.

Curr Diab Rep. 2017 Apr;17(4):23. doi: 10.1007/s11892-017-0847-6. Review. Erratum in: Curr Diab Rep. 2017 Apr;17 (4):29.

5.

Analysis of "Randomized Cross-Over Study Comparing Two Infusion Sets for CSII in Daily Life".

Renard E.

J Diabetes Sci Technol. 2017 Mar;11(2):260-262. doi: 10.1177/1932296816675177. Epub 2016 Oct 23.

PMID:
28264186
6.

Sensor-Augmented Insulin Pumps and Hypoglycemia Prevention in Type 1 Diabetes.

Steineck I, Ranjan A, Nørgaard K, Schmidt S.

J Diabetes Sci Technol. 2017 Jan;11(1):50-58. doi: 10.1177/1932296816672689. Epub 2016 Oct 6.

PMID:
28264173
7.

Improved Postprandial Glycemic Control with Faster-Acting Insulin Aspart in Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion.

Bode BW, Johnson JA, Hyveled L, Tamer SC, Demissie M.

Diabetes Technol Ther. 2017 Jan;19(1):25-33. doi: 10.1089/dia.2016.0350. Epub 2017 Jan 5.

8.
9.

Evaluation of Pump Discontinuation and Associated Factors in the T1D Exchange Clinic Registry.

Wong JC, Boyle C, DiMeglio LA, Mastrandrea LD, Abel KL, Cengiz E, Cemeroglu PA, Aleppo G, Largay JF, Foster NC, Beck RW, Adi S; T1D Exchange Clinic Network.

J Diabetes Sci Technol. 2017 Mar;11(2):224-232. doi: 10.1177/1932296816663963. Epub 2016 Sep 25.

PMID:
27595711
10.

A Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 Diabetes.

King AB, Kuroda A, Matsuhisa M, Hobbs T.

Curr Diab Rep. 2016 Sep;16(9):83. doi: 10.1007/s11892-016-0772-0. Review.

11.

Changes in HbA1c and Weight Following Transition to Continuous Subcutaneous Insulin Infusion Therapy in Adults With Type 1 Diabetes.

Mehta SN, Andersen HU, Abrahamson MJ, Wolpert HA, Hommel EE, McMullen W, Ridderstråle M.

J Diabetes Sci Technol. 2017 Jan;11(1):83-86. doi: 10.1177/1932296816658900. Epub 2016 Jul 11.

12.

Coming of age: the artificial pancreas for type 1 diabetes.

Thabit H, Hovorka R.

Diabetologia. 2016 Sep;59(9):1795-805. doi: 10.1007/s00125-016-4022-4. Epub 2016 Jun 30. Review.

13.
14.

Influences on Technology Use and Efficacy in Type 1 Diabetes.

Franklin V.

J Diabetes Sci Technol. 2016 May 3;10(3):647-55. doi: 10.1177/1932296816639315. Print 2016 May.

15.

Event and Cost Offsets of Switching 20% of the Type 1 Diabetes Population in Germany From Multiple Daily Injections to Continuous Subcutaneous Insulin Infusion: A 4-Year Simulation Model.

Zöllner YF, Ziegler R, Stüve M, Krumreich J, Schauf M.

J Diabetes Sci Technol. 2016 Aug 22;10(5):1142-8. doi: 10.1177/1932296816633720. Print 2016 Sep.

16.

Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement.

Bartlett ST, Markmann JF, Johnson P, Korsgren O, Hering BJ, Scharp D, Kay TW, Bromberg J, Odorico JS, Weir GC, Bridges N, Kandaswamy R, Stock P, Friend P, Gotoh M, Cooper DK, Park CG, OʼConnell P, Stabler C, Matsumoto S, Ludwig B, Choudhary P, Kovatchev B, Rickels MR, Sykes M, Wood K, Kraemer K, Hwa A, Stanley E, Ricordi C, Zimmerman M, Greenstein J, Montanya E, Otonkoski T.

Transplantation. 2016 Feb;100 Suppl 2:S1-44. doi: 10.1097/TP.0000000000001055. No abstract available.

17.

[Continuous insulin therapy versus multiple insulin injections in the management of type 1 diabetes: a longitutinal study].

Ribeiro ME, Del Roio Liberatore Junior R, Custodio R, Martinelli Junior CE.

Rev Paul Pediatr. 2016 Jan-Mar;34(1):86-90. doi: 10.1016/j.rpped.2015.06.011. Epub 2016 Jan 13. Portuguese.

18.

Insulin Aspart in the Management of Diabetes Mellitus: 15 Years of Clinical Experience.

Hermansen K, Bohl M, Schioldan AG.

Drugs. 2016 Jan;76(1):41-74. doi: 10.1007/s40265-015-0500-0. Review.

19.

A case study in open source innovation: developing the Tidepool Platform for interoperability in type 1 diabetes management.

Neinstein A, Wong J, Look H, Arbiter B, Quirk K, McCanne S, Sun Y, Blum M, Adi S.

J Am Med Inform Assoc. 2016 Mar;23(2):324-32. doi: 10.1093/jamia/ocv104. Epub 2015 Sep 2.

20.

Impact of new technologies on diabetes care.

Giani E, Scaramuzza AE, Zuccotti GV.

World J Diabetes. 2015 Jul 25;6(8):999-1004. doi: 10.4239/wjd.v6.i8.999.

Supplemental Content

Support Center